MMA Asset Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
DSA
MMA Asset Management's DGX Position: Q1 2022 in Review
MMA Asset Management sold out of Quest Diagnostics (DGX) in Q1 2022, closing a stake of 1,695 shares — an estimated $293K sold.
MMA Asset Management first reported a position in DGX in Q2 2021 and held it in 3 quarters. The position peaked at $293K in Q4 2021. 851 funds tracked by Wall St. Rank hold DGX as of Q1 2022.
- MMA Asset Management reported no remaining Quest Diagnostics position as of Q1 2022 after selling out during the quarter.
- MMA Asset Management sold 1,695 Quest Diagnostics shares in Q1 2022, an estimated $293K.
- MMA Asset Management first reported a position in Quest Diagnostics in Q2 2021 and held it in 3 quarters.
- MMA Asset Management's Quest Diagnostics position peaked at $293K in Q4 2021.
- 851 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2022.
Based on MMA Asset Management's 13F filing for Q1 2022, filed 13 May 2022.